Functional significance of glycogen synthase kinase-3 regulation by serotonin

Abigail M. Polter, Sufen Yang, Richard S Jope, Xiaohua Li

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Serotonin modulates brain physiology and behavior and has major roles in brain diseases involving abnormal mood and cognition. Enhancing brain serotonin has been found to regulate glycogen synthase Kinase-3 (GSK3), but the signaling mechanism and functional significance of this regulation remain to be determined. In this study, we tested the signaling mechanism mediating 5-HT1A receptor-regulated GSK3 in the hippocampus. Using mutant GSK3 knock-in mice, we also tested the role of GSK3 in the behavioral effects of 5-HT1A receptors and the serotonin reuptake inhibitor fluoxetine. The results showed that activation of 5-HT1A receptors by 8-hydroxy- N, N-dipropyl-2-aminotetralin (8-OH-DPAT) increased phosphorylation of the N-terminal serine of both GSK3α and GSK3β in several areas of the hippocampus. The effect of 8-OH-DPAT was accompanied by an increase in the active phosphorylation of Akt, and was blocked by LY294002, an inhibitor of phosphoinositide 3-kinases (PI3K). Phosphorylation of GSK3β, but not GSK3α, was necessary for 5-HT1A receptors to suppress the hippocampus-associated contextual fear learning. Furthermore, acute fluoxetine treatment up-regulated both phospho-Ser21-GSK3α and phospho-Ser9-GSK3β in the hippocampus. Blocking phosphorylation of GSK3α and GSK3β diminished the anti-immobility effect of fluoxetine treatment in the forced swim test, wherein the effect of GSK3β was more prominent. These results together suggest that PI3K/Akt is a signaling mechanism mediating the GSK3-regulating effect of 5-HT1A receptors in the hippocampus, and regulation of GSK3 is an important intermediate signaling process in the behavioral functions of 5-HT1A receptors and fluoxetine.

Original languageEnglish
Pages (from-to)265-271
Number of pages7
JournalCellular Signalling
Volume24
Issue number1
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Glycogen Synthase Kinase 3
Serotonin
Receptor, Serotonin, 5-HT1A
Fluoxetine
Hippocampus
Phosphorylation
8-Hydroxy-2-(di-n-propylamino)tetralin
1-Phosphatidylinositol 4-Kinase
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Serotonin Uptake Inhibitors
Brain
Brain Diseases

Keywords

  • 5-HT1A
  • Akt
  • Behavior
  • Fluoxetine
  • GSK3
  • Serotonin

ASJC Scopus subject areas

  • Cell Biology

Cite this

Functional significance of glycogen synthase kinase-3 regulation by serotonin. / Polter, Abigail M.; Yang, Sufen; Jope, Richard S; Li, Xiaohua.

In: Cellular Signalling, Vol. 24, No. 1, 01.01.2012, p. 265-271.

Research output: Contribution to journalArticle

Polter, Abigail M. ; Yang, Sufen ; Jope, Richard S ; Li, Xiaohua. / Functional significance of glycogen synthase kinase-3 regulation by serotonin. In: Cellular Signalling. 2012 ; Vol. 24, No. 1. pp. 265-271.
@article{8b1d99c8fdbb4845b8221439cdedd381,
title = "Functional significance of glycogen synthase kinase-3 regulation by serotonin",
abstract = "Serotonin modulates brain physiology and behavior and has major roles in brain diseases involving abnormal mood and cognition. Enhancing brain serotonin has been found to regulate glycogen synthase Kinase-3 (GSK3), but the signaling mechanism and functional significance of this regulation remain to be determined. In this study, we tested the signaling mechanism mediating 5-HT1A receptor-regulated GSK3 in the hippocampus. Using mutant GSK3 knock-in mice, we also tested the role of GSK3 in the behavioral effects of 5-HT1A receptors and the serotonin reuptake inhibitor fluoxetine. The results showed that activation of 5-HT1A receptors by 8-hydroxy- N, N-dipropyl-2-aminotetralin (8-OH-DPAT) increased phosphorylation of the N-terminal serine of both GSK3α and GSK3β in several areas of the hippocampus. The effect of 8-OH-DPAT was accompanied by an increase in the active phosphorylation of Akt, and was blocked by LY294002, an inhibitor of phosphoinositide 3-kinases (PI3K). Phosphorylation of GSK3β, but not GSK3α, was necessary for 5-HT1A receptors to suppress the hippocampus-associated contextual fear learning. Furthermore, acute fluoxetine treatment up-regulated both phospho-Ser21-GSK3α and phospho-Ser9-GSK3β in the hippocampus. Blocking phosphorylation of GSK3α and GSK3β diminished the anti-immobility effect of fluoxetine treatment in the forced swim test, wherein the effect of GSK3β was more prominent. These results together suggest that PI3K/Akt is a signaling mechanism mediating the GSK3-regulating effect of 5-HT1A receptors in the hippocampus, and regulation of GSK3 is an important intermediate signaling process in the behavioral functions of 5-HT1A receptors and fluoxetine.",
keywords = "5-HT1A, Akt, Behavior, Fluoxetine, GSK3, Serotonin",
author = "Polter, {Abigail M.} and Sufen Yang and Jope, {Richard S} and Xiaohua Li",
year = "2012",
month = "1",
day = "1",
doi = "10.1016/j.cellsig.2011.09.009",
language = "English",
volume = "24",
pages = "265--271",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Functional significance of glycogen synthase kinase-3 regulation by serotonin

AU - Polter, Abigail M.

AU - Yang, Sufen

AU - Jope, Richard S

AU - Li, Xiaohua

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Serotonin modulates brain physiology and behavior and has major roles in brain diseases involving abnormal mood and cognition. Enhancing brain serotonin has been found to regulate glycogen synthase Kinase-3 (GSK3), but the signaling mechanism and functional significance of this regulation remain to be determined. In this study, we tested the signaling mechanism mediating 5-HT1A receptor-regulated GSK3 in the hippocampus. Using mutant GSK3 knock-in mice, we also tested the role of GSK3 in the behavioral effects of 5-HT1A receptors and the serotonin reuptake inhibitor fluoxetine. The results showed that activation of 5-HT1A receptors by 8-hydroxy- N, N-dipropyl-2-aminotetralin (8-OH-DPAT) increased phosphorylation of the N-terminal serine of both GSK3α and GSK3β in several areas of the hippocampus. The effect of 8-OH-DPAT was accompanied by an increase in the active phosphorylation of Akt, and was blocked by LY294002, an inhibitor of phosphoinositide 3-kinases (PI3K). Phosphorylation of GSK3β, but not GSK3α, was necessary for 5-HT1A receptors to suppress the hippocampus-associated contextual fear learning. Furthermore, acute fluoxetine treatment up-regulated both phospho-Ser21-GSK3α and phospho-Ser9-GSK3β in the hippocampus. Blocking phosphorylation of GSK3α and GSK3β diminished the anti-immobility effect of fluoxetine treatment in the forced swim test, wherein the effect of GSK3β was more prominent. These results together suggest that PI3K/Akt is a signaling mechanism mediating the GSK3-regulating effect of 5-HT1A receptors in the hippocampus, and regulation of GSK3 is an important intermediate signaling process in the behavioral functions of 5-HT1A receptors and fluoxetine.

AB - Serotonin modulates brain physiology and behavior and has major roles in brain diseases involving abnormal mood and cognition. Enhancing brain serotonin has been found to regulate glycogen synthase Kinase-3 (GSK3), but the signaling mechanism and functional significance of this regulation remain to be determined. In this study, we tested the signaling mechanism mediating 5-HT1A receptor-regulated GSK3 in the hippocampus. Using mutant GSK3 knock-in mice, we also tested the role of GSK3 in the behavioral effects of 5-HT1A receptors and the serotonin reuptake inhibitor fluoxetine. The results showed that activation of 5-HT1A receptors by 8-hydroxy- N, N-dipropyl-2-aminotetralin (8-OH-DPAT) increased phosphorylation of the N-terminal serine of both GSK3α and GSK3β in several areas of the hippocampus. The effect of 8-OH-DPAT was accompanied by an increase in the active phosphorylation of Akt, and was blocked by LY294002, an inhibitor of phosphoinositide 3-kinases (PI3K). Phosphorylation of GSK3β, but not GSK3α, was necessary for 5-HT1A receptors to suppress the hippocampus-associated contextual fear learning. Furthermore, acute fluoxetine treatment up-regulated both phospho-Ser21-GSK3α and phospho-Ser9-GSK3β in the hippocampus. Blocking phosphorylation of GSK3α and GSK3β diminished the anti-immobility effect of fluoxetine treatment in the forced swim test, wherein the effect of GSK3β was more prominent. These results together suggest that PI3K/Akt is a signaling mechanism mediating the GSK3-regulating effect of 5-HT1A receptors in the hippocampus, and regulation of GSK3 is an important intermediate signaling process in the behavioral functions of 5-HT1A receptors and fluoxetine.

KW - 5-HT1A

KW - Akt

KW - Behavior

KW - Fluoxetine

KW - GSK3

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=80755132127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80755132127&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2011.09.009

DO - 10.1016/j.cellsig.2011.09.009

M3 - Article

VL - 24

SP - 265

EP - 271

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 1

ER -